We are live on
!
Find out more
KM
Kalos Management Portfolio holdings
AUM
$46.6M
1-Year Est. Return
11.52%
This Fund
S&P 500
This Quarter
Est. Return
+4.68%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
–
AUM
$186M
AUM Growth
-$34.1M
(-15%)
Cap. Flow
-$39.9M
Cap. Flow
% of AUM
-21.39%
Top 10 Holdings %
Top 10 Hldgs %
33.45%
Holding
233
New
31
Increased
46
Reduced
81
Closed
70
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$8.14M |
| 2 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
+$6.67M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$6.65M |
| 4 |
JPMorgan Chase
JPM
|
+$2.96M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$5.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.15M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$4.71M |
| 4 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$4.59M |
| 5 |
iShares US Basic Materials ETF
IYM
|
+$4.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.18% |
| 2 | Healthcare | 12.33% |
| 3 | Financials | 8.49% |
| 4 | Consumer Discretionary | 6.57% |
| 5 | Industrials | 3.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares S&P 500 Value ETF
IVE
$49.6B
| $243K | 0.13% |
+2,103
| New | +$241K |
|
127
BioCryst Pharmaceuticals
BCRX
$2.42B
| $241K | 0.13% |
31,500
-1,000
| -3% | -$6.72K |
|
128
Coca-Cola
KO
$385B
| $241K | 0.13% |
5,148
-2,898
| -36% | -$132K |
|
129
Procter & Gamble
PG
$355B
| $239K | 0.13% |
2,749
-746
| -21% | -$61K |
|
130
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $238K | 0.13% |
+5,915
| New | +$238K |
|
131
Boeing
BA
$170B
| $233K | 0.13% |
627
-180
| -22% | -$63.2K |
|
132
Ventas
VTR
$48.4B
| $224K | 0.12% |
3,759
-7,296
| -66% | -$422K |
|
133
Mastercard
MA
$495B
| $221K | 0.12% |
+1,036
| New | +$216K |
|
134
Chevron
CVX
$378B
| $219K | 0.12% |
1,798
-312
| -15% | -$37.9K |
|
135
Alphabet (Google) Class A
GOOGL
$4.03T
| $214K | 0.11% |
3,640
-4,680
| -56% | -$283K |
|
|
136
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $212K | 0.11% |
759
-18,094
| -96% | -$5.15M |
|
137
Vanguard Growth ETF
VUG
$215B
| $207K | 0.11% |
+8,040
| New | +$210K |
|
138
Bank of America
BAC
$438B
| $202K | 0.11% |
6,983
-2,565
| -27% | -$78.1K |
|
139
Vanguard Value ETF
VTV
$191B
| $200K | 0.11% |
+1,835
| New | +$200K |
|
140
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
| $196K | 0.11% |
+11,146
| New | +$192K |
|
141
Gyre Therapeutics
GYRE
$668M
| $180K | 0.1% |
2,308
+1,175
| +104% | +$93.1K |
|
142
Cytosorbents Corp
CTSO
$23.2M
| $176K | 0.09% |
14,700
-2,950
| -17% | -$37K |
|
|
MAV
143
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
| $175K | 0.09% |
16,400
-866
| -5% | -$9.5K |
|
144
Invesco Municipal Trust
VKQ
$540M
| $165K | 0.09% |
14,750
| – | – |
|
145
GE Aerospace
GE
$373B
| $164K | 0.09% |
3,263
+932
| +40% | +$57.4K |
|
146
Verastem
VSTM
$539M
| $144K | 0.08% |
+1,875
| New | +$186K |
|
|
PHK
147
PIMCO High Income Fund
PHK
$863M
| $140K | 0.08% |
16,801
+3,848
| +30% | +$33.5K |
|
|
SNMP
148
DELISTED
Evolve Transition Infrastructure LP
SNMP
| $138K | 0.07% |
652
+124
| +23% | +$37.3K |
|
|
FOLD
149
DELISTED
Amicus Therapeutics
FOLD
| $126K | 0.07% |
+10,750
| New | +$150K |
|
|
ESV
150
DELISTED
Ensco Rowan plc
ESV
| $120K | 0.06% |
3,900
-812
| -17% | -$23.2K |
|
Similar funds
IM
UCIG
KP
NH
DCM
VCM
FGIM
WGRM
Kalos Management's Q3 2018 Portfolio in Review
As of Q3 2018, Kalos Management held 233 positions worth $186M, down 15% from $221M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Kalos Management withdrew a net $39.9M in Q3 2018, closing 70 positions and reducing 81 holdings. Its most notable exit was Schwab US Large- Cap ETF, an estimated $5.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Kalos Management opened a new position in JPMorgan Chase worth $2.9M.
- Kalos Management's largest Q3 2018 buy was JPMorgan Chase: 26,101 shares worth $2.9M.
- Kalos Management added most to iShares S&P 500 Growth ETF in Q3 2018, an estimated $8.14M increase.
- Kalos Management's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.15M.
- Kalos Management fully exited Schwab US Large- Cap ETF in Q3 2018, selling an estimated $5.6M.
- Kalos Management's ten largest holdings make up 33% of its $186M portfolio in Q3 2018.
- Kalos Management opened 31 new positions and closed 70 in Q3 2018.
- Kalos Management's portfolio value fell 15% quarter-over-quarter to $186M.
Based on Kalos Management's 13F filing for Q3 2018, filed 14 Nov 2018.